Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1977 1
1979 1
1980 1
1981 5
1982 1
1984 2
1985 14
1986 3
1987 2
1988 4
1989 3
1990 1
1991 1
1992 1
1993 2
1994 2
1995 1
1996 2
1997 2
1999 1
2001 1
2002 2
2003 4
2004 1
2005 2
2006 1
2007 1
2009 2
2010 4
2011 7
2012 6
2013 7
2014 5
2015 11
2016 6
2017 5
2018 6
2019 10
2020 8
2021 5
2022 2
2023 4
2024 9
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Adverse Childhood Experiences, Outcomes, and Interventions.
Gilgoff R, Singh L, Koita K, Gentile B, Marques SS. Gilgoff R, et al. Among authors: gentile b. Pediatr Clin North Am. 2020 Apr;67(2):259-273. doi: 10.1016/j.pcl.2019.12.001. Pediatr Clin North Am. 2020. PMID: 32122559 Review.
The complement C5 inhibitor crovalimab in paroxysmal nocturnal hemoglobinuria.
Röth A, Nishimura JI, Nagy Z, Gaàl-Weisinger J, Panse J, Yoon SS, Egyed M, Ichikawa S, Ito Y, Kim JS, Ninomiya H, Schrezenmeier H, Sica S, Usuki K, Sicre de Fontbrune F, Soret J, Sostelly A, Higginson J, Dieckmann A, Gentile B, Anzures-Cabrera J, Shinomiya K, Jordan G, Biedzka-Sarek M, Klughammer B, Jahreis A, Bucher C, Peffault de Latour R. Röth A, et al. Among authors: gentile b. Blood. 2020 Mar 19;135(12):912-920. doi: 10.1182/blood.2019003399. Blood. 2020. PMID: 31978221 Free PMC article. Clinical Trial.
Situs Inversus Totalis.
Gentile BA, Tighe DA. Gentile BA, et al. N Engl J Med. 2019 Jun 13;380(24):e45. doi: 10.1056/NEJMicm1811002. N Engl J Med. 2019. PMID: 31189040 No abstract available.
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition.
Röth A, He G, Tong H, Lin Z, Wang X, Chai-Adisaksopha C, Lee JH, Brodsky A, Hantaweepant C, Dumagay TE, Demichelis-Gómez R, Rojnuckarin P, Sun J, Höglund M, Jang JH, Gaya A, Silva F, Obara N, Kelly RJ, Beveridge L, Buatois S, Chebon S, Gentile B, Lundberg P, Sreckovic S, Nishimura JI, Risitano A, Han B. Röth A, et al. Among authors: gentile b. Am J Hematol. 2024 Sep;99(9):1768-1777. doi: 10.1002/ajh.27412. Epub 2024 Jun 17. Am J Hematol. 2024. PMID: 38884175 Clinical Trial.
Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor-experienced patients with paroxysmal nocturnal hemoglobinuria.
Scheinberg P, Clé DV, Kim JS, Nur E, Yenerel MN, Barcellini W, Bonito D, Giai V, Hus M, Lee Y, Lekue CB, Panse J, Ueda Y, Buatois S, Gentile B, Kiialainen A, Patel H, Sreckovic S, Uguen M, Edwards J, Nagy Z, Kulasekararaj AG. Scheinberg P, et al. Among authors: gentile b. Am J Hematol. 2024 Sep;99(9):1757-1767. doi: 10.1002/ajh.27413. Epub 2024 Jun 25. Am J Hematol. 2024. PMID: 38924124 Clinical Trial.
Residuals, sludge, and biosolids: Advancements in the field.
Brisolara KB, Gentile B, Puszykowski K, Bourgeois J. Brisolara KB, et al. Among authors: gentile b. Water Environ Res. 2020 Oct;92(10):1541-1551. doi: 10.1002/wer.1402. Epub 2020 Aug 9. Water Environ Res. 2020. PMID: 32668078 Review.
Patient Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.
Holekamp N, Gentile B, Giocanti-Aurégan A, García-Layana A, Peto T, Viola F, Kertes PJ, Mirt M, Kotecha A, Lambert J, Lewis HB, Chi GC. Holekamp N, et al. Among authors: gentile b. Ophthalmic Res. 2024;67(1):311-321. doi: 10.1159/000538975. Epub 2024 Apr 29. Ophthalmic Res. 2024. PMID: 38679018 Free article.
Health-related quality of life with fixed-duration venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial.
Al-Sawaf O, Gentile B, Devine J, Zhang C, Sail K, Tandon M, Fink AM, Kutsch N, Wendtner CM, Eichhorst B, Hallek M, Fischer K. Al-Sawaf O, et al. Among authors: gentile b. Am J Hematol. 2021 Sep 1;96(9):1112-1119. doi: 10.1002/ajh.26260. Epub 2021 Jun 22. Am J Hematol. 2021. PMID: 34050972 Free article. Clinical Trial.
141 results